Home › Neuroblastoma › Arkansas
Neuroblastoma clinical trials in Arkansas
6 studies for Neuroblastoma are looking for participants at sites in Arkansas.
Cities in Arkansas
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 3
Up to age 30 · All sexes · Updated Oct 2, 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 2
Up to age 22 · All sexes · Updated Sep 4, 2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 1/2
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 2
Ages 1 to 21 · All sexes · Updated Sep 3, 2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 3
365 Days – 30 Years · All sexes · Updated Aug 25, 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 2
12 Months – 21 Years · All sexes · Updated Aug 12, 2026 · NCT05489887From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.